Yale’s Impact on America

Yale makes a difference for Americans across the country — by advancing life-saving medical treatments, developing cutting-edge technology that increases national competitiveness and drives economic growth, and expanding educational opportunities for the country’s brightest students.

“A major driver of this success is our longstanding partnership with the federal government and the support of the American people. For decades, the government and universities have worked together to invest in critical research and foster innovation.”
—Maurie McInnis, Yale University President

Our research helps save lives.

Yale research has pioneered advances in health and medicine, including the development of innovative treatments and devices that extend and enhance life for patients with heart defects, Alzheimer’s, diabetes, and many other conditions. Our large-scale clinical trials—38,000 patients are currently enrolled in over 2,000 clinical trials—are yielding key discoveries that translate into life-saving therapies.

Our research helps save lives.

Chemotherapy launched at Yale

about 1 million people receive this life-saving treatment every year

Yale developed the first insulin pump

a device used by about 350,000 people per year

Yale identified Lyme disease

resulting in treatments for nearly 476,000 people each year

First U.S. artificial heart pump developed by Yale

helping over 6 million Americans living with heart failure

Discoveries in cancer immunotherapy: Because of immune checkpoint inhibitors, patients are extending their lifespan and even experiencing remission. Yale Cancer Center has led several clinical trials in this area, including for nivolumab and pembrolizumab, which have led to FDA approvals based on unprecedented patient outcomes.

Care for premature babies: Surfactant therapy reduces mortality in very premature babies by up to 50%. In just the U.S., over 30,000 preterm infants are saved every year through therapies Yale helped advance.

Delaying the onset of juvenile diabetes: A Yale scientist conducted four clinical trials of teplizumab, leading to the first FDA-approved drug that delays the onset of type 1 diabetes by as much as ten years.

Advances for treatment-resistant depression: Yale research led to the discovery of esketamine as a therapy for major depression, which the FDA approved in 2019 as the first new medication in decades for people suffering from treatment-resistant depression.

Our work strengthens American leadership and security.

Our research is helping America advance its competitive edge in fields like artificial intelligence and quantum computing. Faculty and student work in these fields is transforming how society can better combat disease, prevent cybersecurity attacks, and produce breakthroughs ranging from battery technology to drug development.

Our work strengthens American leadership and security.

$1.5 billion investment in research facilities and infrastructure to advance quantum science, engineering, and materials science

$150 million investment to harness the potential of artificial intelligence

Revolutionary advances in quantum computing: Yale researchers pioneered the development of solid-state quantum bits and created the new field of circuit quantum electrodynamics, a critical advance in the development of practical quantum computers. The first electronic quantum processor was also invented at Yale, producing many firsts in the field.

Understanding aortic aneurysms: Using artificial intelligence technology, Yale researchers discovered how aortic aneurysms develop. This breakthrough allows doctors to target disease-prone cells and provide patients with targeted therapy.

We are expanding educational opportunities.

Yale provides an exceptional education for students who come from all 50 states and from a wide range of backgrounds. Comprehensive financial aid ensures that all admitted students can attend, regardless of financial need.

We are expanding educational opportunities.

55% of undergrads receive financial aid
average aid is $68K

85% of undergrads graduate debt free
average debt is less than half of the national average

Yale is need-blind in admissions, meaning financial need is not considered

1 in 4 of first-year class receives Pell Grants

7x more veterans in Yale’s first-year class compared to a decade ago

1 in 5 of the class of 2028 is first in family to attend college

Our graduates build a better tomorrow.

Our students go on to contribute to both public and private sectors across all 50 states — helping maintain America’s leadership in the sciences and technology, arts and culture, and public service.

Based on 2024 data of Yale College graduates

97%

five-year graduation rate

94%

undergrads employed or in grad school within 6 mo.

89%

graduates working or studying in all 50 states

1 in 3

recent graduating seniors took jobs in public sector

We help power the nation’s economy.

Research that begins in Yale’s labs has a measurable impact on the American economy. New technologies, startup ventures, and discoveries from Yale faculty and students create jobs and opportunities across the country.

$8B

economic impact per year

$6B

in capital raised by Yale startups in the last seven years

2,233

active patents around the world

We are investing in America’s future.

Yale’s investment into groundbreaking research and the education of the country’s most talented students is an investment in America. These contributions help accelerate new technologies, support the growth of industries and companies, and creates jobs in New Haven and across the country.

Data reflects investments made in FY24

$432M

invested in research

$564M

student financial aid

$250M

to support development of future leaders in health care

$149M

in support of faculty for teaching and research

Research for the greater good

From cancer discoveries to mental health research, see the impact of our work.

What’s at stake